Clinical and Molecular Hepatology,
Journal Year:
2020,
Volume and Issue:
27(1), P. 1 - 21
Published: Dec. 3, 2020
Primary
biliary
cholangitis
(PBC)
causes
chronic
and
persistent
cholestasis
in
the
liver,
eventually
resulting
cirrhosis
hepatic
failure
without
appropriate
treatment.
PBC
mainly
develops
middle-aged
women,
but
it
is
also
common
young
women
men.
considered
a
model
of
autoimmune
disease
because
presence
diseasespecific
autoantibodies,
that
is,
antimitochondrial
antibodies
(AMAs),
intense
infiltration
mononuclear
cells
into
bile
ducts,
high
prevalence
diseases
such
as
comorbidities.
Histologically,
characterized
by
degeneration
necrosis
intrahepatic
epithelial
surrounded
dense
cells,
coined
non-suppurative
destructive
cholangitis,
which
leads
to
changes
disappearance
small-
or
medium-sized
ducts.
Since
1990,
early
diagnosis
with
detection
AMAs
introduction
ursodeoxycholic
acid
first-line
treatment
has
greatly
altered
clinical
course
PBC,
liver
transplantation-free
survival
patients
now
comparable
general
population.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(2), P. 699 - 699
Published: Feb. 22, 2021
The
most
prevalent
diseases
of
our
time,
non-communicable
(NCDs)
(including
obesity,
type
2
diabetes,
cardiovascular
and
some
types
cancer)
are
rising
worldwide.
All
them
share
the
condition
an
“inflammatory
disorder”,
with
impaired
immune
functions
frequently
caused
or
accompanied
by
alterations
in
gut
microbiota.
These
multifactorial
maladies
also
have
common
malnutrition
related
to
physiopathology.
In
this
context,
diet
is
greatest
modulator
system–microbiota
crosstalk,
much
interest,
new
challenges,
arising
area
precision
nutrition
as
a
way
towards
treatment
prevention.
It
fact
that
westernized
(WD)
partly
responsible
for
increased
prevalence
NCDs,
negatively
affecting
both
microbiota
system.
Conversely,
other
nutritional
approaches,
such
Mediterranean
(MD),
positively
influence
system
microbiota,
proposed
not
only
potential
tool
clinical
management
different
disease
conditions,
but
prevention
health
promotion
globally.
Thus,
purpose
review
determine
regulatory
role
components
WD
MD
interplay,
order
understand,
create
awareness
of,
over
key
components.
Annual Review of Immunology,
Journal Year:
2020,
Volume and Issue:
38(1), P. 147 - 170
Published: April 26, 2020
Metabolism
is
one
of
the
strongest
drivers
interkingdom
interactions—including
those
between
microorganisms
and
their
multicellular
hosts.
Traditionally
thought
to
fuel
energy
requirements
provide
building
blocks
for
biosynthetic
pathways,
metabolism
now
appreciated
its
role
in
providing
metabolites,
small-molecule
intermediates
generated
from
metabolic
processes,
perform
various
regulatory
functions
mediate
symbiotic
relationships
microbes
Here,
we
review
recent
advances
our
mechanistic
understanding
how
microbiota-derived
metabolites
orchestrate
support
physiological
responses
host,
including
immunity,
inflammation,
defense
against
infections,
metabolism.
Understanding
metabolically
communicate
with
hosts
will
us
an
opportunity
better
describe
a
host
interacts
all
microbes—beneficial,
pathogenic,
commensal—and
discover
new
ways
treat
microbial-driven
diseases.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2020,
Volume and Issue:
62(13), P. 3509 - 3534
Published: Dec. 30, 2020
Aging
is
characterized
by
the
functional
decline
of
tissues
and
organs
increased
risk
aging-associated
disorders,
which
pose
major
societal
challenges
are
a
public
health
priority.
Despite
extensive
human
genetics
studies,
limited
progress
has
been
made
linking
with
aging.
There
growing
realization
that
altered
assembly,
structure
dynamics
gut
microbiota
actively
participate
in
aging
process.
Age-related
microbial
dysbiosis
involved
reshaping
immune
responses
during
aging,
manifest
as
immunosenescence
(insufficiency)
inflammaging
(over-reaction)
accompany
many
age-associated
enteric
extraenteric
diseases.
The
can
be
regulated,
suggesting
potential
target
for
interventions.
This
review
summarizes
recent
findings
on
physiological
succession
across
life-cycle,
roles
mechanisms
healthy
alterations
diseases,
microbiota-targeted
anti-aging
strategies.
Gut Microbes,
Journal Year:
2021,
Volume and Issue:
13(1)
Published: Jan. 1, 2021
The
interaction
disorder
between
gut
microbiota
and
its
host
has
been
documented
in
different
non-communicable
diseases
(NCDs)
such
as
metabolic
syndrome,
neurodegenerative
disease,
autoimmune
disease.
majority
of
these
altered
interactions
arise
through
cross-talk
immune
system,
inducing
a
low-grade
chronic
inflammation
that
characterizes
all
NCDs.
In
this
review,
we
discuss
the
contribution
bacterial
metabolites
to
signaling
pathways
involved
We
then
review
recent
advances
aid
rationally
design
microbial
therapeutics.
A
deeper
understanding
intersections
metabolism
using
metabolomics-based
system
biology
platform
promises
reveal
fundamental
mechanisms
drive
predispositions
disease
suggest
new
avenues
use
therapeutic
opportunities
for
NCDs
treatment
prevention.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(9), P. 3143 - 3143
Published: Sept. 9, 2021
Inflammatory
bowel
disease
(IBD)
is
a
chronic,
relapsing
inflammatory
disorder
of
the
gastrointestinal
tract,
with
increasing
prevalence,
and
its
pathogenesis
remains
unclear.
Accumulating
evidence
suggested
that
gut
microbiota
bile
acids
play
pivotal
roles
in
intestinal
homeostasis
inflammation.
Patients
IBD
exhibit
decreased
microbial
diversity
abnormal
composition
marked
by
depletion
phylum
Firmicutes
(including
bacteria
involved
acid
metabolism)
enrichment
Proteobacteria.
Dysbiosis
leads
to
blocked
transformation.
Thus,
concentration
primary
conjugated
elevated
at
expense
secondary
IBD.
In
turn,
could
modulate
community.
Gut
dysbiosis
disturbed
impair
barrier
immunity.
Several
therapies,
such
as
diets,
probiotics,
prebiotics,
engineered
bacteria,
fecal
transplantation
ursodeoxycholic
acid,
may
alleviate
restoring
acids.
acid-gut
axis
closely
connected
pathogenesis.
Regulation
this
be
novel
option
for
treating
Journal of Hepatology,
Journal Year:
2021,
Volume and Issue:
75(3), P. 572 - 581
Published: May 23, 2021
Primary
biliary
cholangitis
(PBC)
is
a
chronic
liver
disease
in
which
autoimmune
destruction
of
the
small
intrahepatic
bile
ducts
eventually
leads
to
cirrhosis.
Many
patients
have
inadequate
response
licensed
medications,
motivating
search
for
novel
therapies.
Previous
genome-wide
association
studies
(GWAS)
and
meta-analyses
(GWMA)
PBC
identified
numerous
risk
loci
this
condition,
providing
insight
into
its
aetiology.
We
undertook
largest
GWMA
date,
aiming
identify
additional
prioritise
candidate
genes
silico
drug
efficacy
screening.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 294 - 294
Published: Jan. 20, 2023
Gut
microbes
and
their
metabolites
are
actively
involved
in
the
development
regulation
of
host
immunity,
which
can
influence
disease
susceptibility.
Herein,
we
review
most
recent
research
advancements
gut
microbiota–immune
axis.
We
discuss
detail
how
microbiota
is
a
tipping
point
for
neonatal
immune
as
indicated
by
newly
uncovered
phenomenon,
such
maternal
imprinting,
utero
intestinal
metabolome,
weaning
reaction.
describe
shapes
both
innate
adaptive
immunity
with
emphasis
on
short-chain
fatty
acids
secondary
bile
acids.
also
comprehensively
delineate
disruption
axis
results
immune-mediated
diseases,
gastrointestinal
infections,
inflammatory
bowel
cardiometabolic
disorders
(e.g.,
cardiovascular
diabetes,
hypertension),
autoimmunity
rheumatoid
arthritis),
hypersensitivity
asthma
allergies),
psychological
anxiety),
cancer
colorectal
hepatic).
further
encompass
role
fecal
transplantation,
probiotics,
prebiotics,
dietary
polyphenols
reshaping
therapeutic
potential.
Continuing,
examine
modulates
therapies,
including
checkpoint
inhibitors,
JAK
anti-TNF
therapies.
lastly
mention
current
challenges
metagenomics,
germ-free
models,
recapitulation
to
achieve
fundamental
understanding
regulates
immunity.
Altogether,
this
proposes
improving
immunotherapy
efficacy
from
perspective
microbiome-targeted
interventions.
Acta Pharmaceutica Sinica B,
Journal Year:
2021,
Volume and Issue:
12(5), P. 2129 - 2149
Published: Dec. 22, 2021
Cardiometabolic
disease
(CMD),
characterized
with
metabolic
disorder
triggered
cardiovascular
events,
is
a
leading
cause
of
death
and
disability.
Metabolic
disorders
trigger
chronic
low-grade
inflammation,
actually,
new
concept
metaflammation
has
been
proposed
to
define
the
state
metabolism
connected
immunological
adaptations.
Amongst
continuously
increased
list
systemic
metabolites
in
regulation
immune
system,
bile
acids
(BAs)
represent
distinct
class
implicated
whole
process
CMD
development
because
its
multifaceted
roles
shaping
immunometabolism.
BAs
can
directly
modulate
system
by
either
boosting
or
inhibiting
inflammatory
responses
via
diverse
mechanisms.
Moreover,
are
key
determinants
maintaining
dynamic
communication
between
host
microbiota.
Importantly,
targeting
Farnesoid
X
receptor
(FXR)
other
nuclear
receptors
play
regulating
homeostasis
lipids,
glucose,
amino
acids.
axis
per
se
susceptible
intervention,
thereby
may
constitute
reciprocal
regulatory
loop
metaflammation.
We
thus
propose
that
represents
core
coordinator
integrating
immunometabolism
CMD.
provide
an
updated
summary
intensive
discussion
about
how
shape
both
innate
adaptive
function
as
inflammation
conditions